Viva Biotech Holdings
Viva Biotech Holdings, a leading player in the biotechnology sector, is headquartered in China (CN) and operates extensively across Asia and beyond. Founded in 2008, the company has established itself as a prominent provider of drug discovery services, specialising in structure-based drug design and high-throughput screening. Viva Biotech's unique offerings include its proprietary technology platforms that enhance the efficiency of drug development processes, setting it apart in a competitive market. With a strong focus on innovation, the company has achieved significant milestones, including collaborations with major pharmaceutical firms and a robust portfolio of successful projects. Recognised for its expertise and commitment to advancing biopharmaceutical research, Viva Biotech Holdings continues to solidify its position as a trusted partner in the global biotech landscape.
DitchCarbon Score
How does Viva Biotech Holdings's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Viva Biotech Holdings's score of 15 is lower than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Viva Biotech Holdings's reported carbon emissions
In 2021, Viva Biotech Holdings reported total carbon emissions of approximately 37,456,150 kg CO2e, with Scope 1 emissions at about 958,110 kg CO2e and Scope 2 emissions at approximately 36,499,030 kg CO2e. The company has set ambitious reduction targets, aiming to cut its carbon emissions by 50% by 2030, specifically within its CDMO segment. This commitment includes a reduction in water consumption per RMB 10,000 of revenue by 25% by 2025 and a 50% reduction in solid waste generation per RMB 10,000 of revenue by the same year, using 2020 as the baseline year. For 2020, the company reported Scope 1 and 2 emissions of approximately 2,835,960 kg CO2e, with Scope 1 emissions at about 24,020 kg CO2e and Scope 2 emissions at approximately 2,812,330 kg CO2e. In 2019, the total emissions were approximately 2,105,170 kg CO2e, with Scope 1 at about 22,400 kg CO2e and Scope 2 at approximately 2,083,120 kg CO2e. Viva Biotech's ongoing efforts reflect a commitment to sustainability and reducing its environmental impact, aligning with industry standards for climate action.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | |
|---|---|---|
| Scope 1 | 152,010 | 000,000 |
| Scope 2 | 27,929,350 | 00,000,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Viva Biotech Holdings is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
